Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis

Wang, Tzu-Fei; Kou, Roger; Carrier, Marc; Delluc, Aurélien

doi:10.1016/j.jtha.2023.11.017

Journal of Thrombosis and Haemostasis

2024

DOI: 10.1016/j.jtha.2023.11.017

|View full text |Cite

Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis

Tzu-Fei Wang,

Roger Kou,

Marc Carrier

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite1

Independent2

Authors

Journals

Cited by 3 publications

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Catheter‐related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs

Girardi,

Di Nisio,

Candeloro

et al. 2024

Eur J Clin Investigation

View full text Add to dashboard Cite

BackgroundCatheter‐related thrombosis (CRT) is one of the major complications affecting patients with indwelling venous catheters, usually involving the upper extremity deep venous system. This condition can lead to potentially life‐threatening complications such as pulmonary embolism and sepsis. The risk of developing CRT varies depending on type of catheters and patient characteristics. Despite advances in materials and technologies, the actual incidence of CRT is still considerable. Available evidence on CRT management remains controversial, and clinical guidelines base their recommendations on data from non‐catheter related upper extremity or lower extremity deep venous thromboses.AimsThis narrative review aims to describe the epidemiology of CRT, to review the available evidence on its management and to highlight the current unmet needs.MethodsNo formal search strategy was applied for the revision of the literature. The main sources of information used were Medline and guidelines from international societies.ContentThe management of CRT requires a careful balance between the risk of thrombus progression, recurrent events, and systemic embolization and the increased bleeding risk in often fragile patients. Open issues include the optimal management of the catheter and the type and duration of anticoagulant therapy. Direct oral anticoagulants are increasingly prescribed, representing an important alternative to the standard of care low molecular weight heparins in selected cases. The development of new anticoagulant drugs such as factors XI and XII inhibitors may offer further advantages in this context.ConclusionsThe management of CRT is still challenging with constant need for updated evidence to support tailored approaches.

show abstract

Catheter‐related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs

Girardi,

Di Nisio,

Candeloro

et al. 2024

Eur J Clin Investigation

View full text Add to dashboard Cite

show abstract

Treatment of VTE in the thrombocytopenic cancer patient

Moik,

2024

Hematology

View full text Add to dashboard Cite

Thrombocytopenia is a frequent complication in patients with cancer, mostly due to the myelosuppressive effects of antineoplastic therapies. The risk of venous thromboembolism (VTE) in patients with cancer is increased despite low platelet counts. The management of cancer-associated VTE in patients with thrombocytopenia is challenging, as the risk of both recurrent VTE and bleeding complications is high. Moreover, the time-dependent nature of thrombocytopenia over the course of antineoplastic therapies further complicates the management of patients in clinical practice. In the absence of evidence from high-quality studies, the management of anticoagulation therapy for VTE must be personalized, balancing the individual risk of VTE progression and recurrence against the risk of hemorrhage. In the present case-based review, we highlight the clinical challenges that arise upon managing cancer-associated VTE in the setting of present or anticipated thrombocytopenia, summarize the available evidence, and provide a comparative overview of available guidelines.

show abstract

Venous thromboembolism and mortality in patients with hematological malignancies

Sanfilippo,

Wang

2024

Bleed Thromb Vascul Biol

Self Cite

View full text Add to dashboard Cite

Mortality and venous thromboembolism (VTE) are major risks for patients with hematological malignancies. However, they are commonly underrepresented in major clinical trials of VTE. Treatment decisions are further complicated by the unique characteristics they frequently exhibit, such as thrombocytopenia. In addition to discussing treatment challenges, knowledge gaps, and future directions, our goal in this narrative review is to provide an overview of the epidemiology and risk factors of mortality in patients with hematological malignancies and VTE.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis

Cited by 3 publications

References 35 publications

Catheter‐related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs

Catheter‐related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs

Treatment of VTE in the thrombocytopenic cancer patient

Venous thromboembolism and mortality in patients with hematological malignancies

Contact Info

Product

Resources

About